128 related articles for article (PubMed ID: 11277206)
21. A novel small RNA Bmsr1 enhances virulence in Brucella melitensis M28.
Xu D; Song J; Li G; Cai W; Zong S; Li Z; Liu W; Hu S; Bu Z
Vet Microbiol; 2018 Sep; 223():1-8. PubMed ID: 30173733
[TBL] [Abstract][Full Text] [Related]
22. Pathophysiology of the rhesus macaque model for inhalational brucellosis.
Henning LN; Miller SM; Pak DH; Lindsay A; Fisher DA; Barnewall RE; Briscoe CM; Anderson MS; Warren RL
Infect Immun; 2012 Jan; 80(1):298-310. PubMed ID: 22064715
[TBL] [Abstract][Full Text] [Related]
23. Characterization of an intratracheal aerosol challenge model of Brucella melitensis in guinea pigs.
Hensel ME; Garcia-Gonzalez DG; Chaki SP; Samuel J; Arenas-Gamboa AM
PLoS One; 2019; 14(3):e0212457. PubMed ID: 30835758
[TBL] [Abstract][Full Text] [Related]
24. Effects of gamma radiation and azathioprine on Brucella abortus infection in BALB/c mice.
Elzer PH; Rowe GE; Enright FM; Winter AJ
Am J Vet Res; 1991 Jun; 52(6):838-44. PubMed ID: 1909103
[TBL] [Abstract][Full Text] [Related]
25. Acute Brucella melitensis M16 infection model in mice treated with tumor necrosis factor-alpha inhibitors.
Kutlu M; Ergin Ç; Şen-Türk N; Sayin-Kutlu S; Zorbozan O; Akalın Ş; Şahin B; Çobankara V; Demirkan N
J Infect Dev Ctries; 2015 Feb; 9(2):141-8. PubMed ID: 25699488
[TBL] [Abstract][Full Text] [Related]
26. Pathological changes and bacteriological assessments in the urinary tract of pregnant goats experimentally infected with Brucella melitensis.
Mazlina M; Khairani-Bejo S; Hazilawati H; Tiagarahan T; Shaqinah NN; Zamri-Saad M
BMC Vet Res; 2018 Jun; 14(1):203. PubMed ID: 29940976
[TBL] [Abstract][Full Text] [Related]
27. Aerosol infection of BALB/c mice with Brucella melitensis and Brucella abortus and protective efficacy against aerosol challenge.
Kahl-McDonagh MM; Arenas-Gamboa AM; Ficht TA
Infect Immun; 2007 Oct; 75(10):4923-32. PubMed ID: 17664263
[TBL] [Abstract][Full Text] [Related]
28. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
[TBL] [Abstract][Full Text] [Related]
29. Characterization of Brucella canis infection in mice.
Stranahan LW; Khalaf OH; Garcia-Gonzalez DG; Arenas-Gamboa AM
PLoS One; 2019; 14(6):e0218809. PubMed ID: 31220185
[TBL] [Abstract][Full Text] [Related]
30. In Situ Characterization of Splenic Brucella melitensis Reservoir Cells during the Chronic Phase of Infection in Susceptible Mice.
Hanot Mambres D; Machelart A; Vanderwinden JM; De Trez C; Ryffel B; Letesson JJ; Muraille E
PLoS One; 2015; 10(9):e0137835. PubMed ID: 26376185
[TBL] [Abstract][Full Text] [Related]
31. Cell mediated immune response in goats after experimental challenge with the virulent Brucella melitensis strain 16M and the reduced virulence strain Rev. 1.
Higgins JL; Bowen RA; Gonzalez-Juarrero M
Vet Immunol Immunopathol; 2018 Aug; 202():74-84. PubMed ID: 30078602
[TBL] [Abstract][Full Text] [Related]
32. Shedding of Brucella melitensis happens through milk macrophages in the murine model of infection.
Jansen W; Demars A; Nicaise C; Godfroid J; de Bolle X; Reboul A; Al Dahouk S
Sci Rep; 2020 Jun; 10(1):9421. PubMed ID: 32523093
[TBL] [Abstract][Full Text] [Related]
33. Immunopathological responses and kinetics of Brucella melitensis Rev 1 infection after subcutaneous or conjunctival vaccination in rams.
Muñoz PM; de Miguel MJ; Grilló MJ; Marín CM; Barberán M; Blasco JM
Vaccine; 2008 May; 26(21):2562-9. PubMed ID: 18423950
[TBL] [Abstract][Full Text] [Related]
34. Nasal immunization with recombinant Brucella melitensis bp26 and trigger factor with cholera toxin reduces B. melitensis colonization.
Yang X; Walters N; Robison A; Trunkle T; Pascual DW
Vaccine; 2007 Mar; 25(12):2261-8. PubMed ID: 17239499
[TBL] [Abstract][Full Text] [Related]
35. Establishment of systemic Brucella melitensis infection through the digestive tract requires urease, the type IV secretion system, and lipopolysaccharide O antigen.
Paixão TA; Roux CM; den Hartigh AB; Sankaran-Walters S; Dandekar S; Santos RL; Tsolis RM
Infect Immun; 2009 Oct; 77(10):4197-208. PubMed ID: 19651862
[TBL] [Abstract][Full Text] [Related]
36. Nramp1 is not a major determinant in the control of Brucella melitensis infection in mice.
Guilloteau LA; Dornand J; Gross A; Olivier M; Cortade F; Vern YL; Kerboeuf D
Infect Immun; 2003 Feb; 71(2):621-8. PubMed ID: 12540538
[TBL] [Abstract][Full Text] [Related]
37. Immunogenic properties of Brucella melitensis cell-wall fractions in BALB/c mice.
Cloeckaert A; Jacques I; Limet JN; Dubray G
J Med Microbiol; 1995 Mar; 42(3):200-8. PubMed ID: 7884802
[TBL] [Abstract][Full Text] [Related]
38. Comparison of Brucella abortus and Brucella melitensis infections of mice and their effect on acquired cellular resistance.
Young EJ; Gomez CI; Yawn DH; Musher DM
Infect Immun; 1979 Nov; 26(2):680-5. PubMed ID: 121113
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of several antibiotic combinations against Brucella melitensis Rev 1 experimental infection in BALB/c mice.
Grilló MJ; De Miguel MJ; Muñoz PM; Marín CM; Ariza J; Blasco JM
J Antimicrob Chemother; 2006 Sep; 58(3):622-6. PubMed ID: 16849379
[TBL] [Abstract][Full Text] [Related]
40. Bacterial persistence and immunity in goats vaccinated with a purE deletion mutant or the parental 16M strain of Brucella melitensis.
Cheville NF; Olsen SC; Jensen AE; Stevens MG; Florance AM; Houng HS; Drazek ES; Warren RL; Hadfield TL; Hoover DL
Infect Immun; 1996 Jul; 64(7):2431-9. PubMed ID: 8698463
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
